Search references for IC50. Phrases containing IC50
See searches and references containing IC50!IC50
Half maximal inhibitory concentration
inhibitory concentration (IC50) is a measure of the potency of a substance in inhibiting a specific biological or biochemical function. IC50 is a quantitative
IC50
Group of chemical compounds
amoebas Dictyostelium discoideum (IC50 = 4.4 nM), Acanthamoeba castellanii (IC50 = 2.0 μM), and Acanthamoeba comandoni (IC50 = 3.1 μM) which cause infections
Keanumycin
Pharmaceutical compound
(HDAC1 IC50 = 0.240 µM, HDAC2 IC50 = 0.120 µM, HDAC3 IC50 = 0.155 µM, HDAC5 IC50 > 80 µM, HDAC6 IC50 > 80 µM), such as CI‐994 (3) (HDAC1 IC50 = 0.145
Tianeptinaline
Class of chemical compounds
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
Substituted naphthylethylamine
Substituted_naphthylethylamine
Muscle relaxant medication
5HT2a (IC50 = 92 nM) by Ca+ mobilization. CBP is also an antagonist on 5HT2b (IC50 = 100 nM). CBP and nCBP are functional antagonists on 5HT2c (IC50 = 0
Cyclobenzaprine
Chemical compound
factor receptor (VEGFR) 1/2 receptor family tyrosine kinases inhibitor with IC50 of 2, 6, 77, 59 nM for EGFR, ErbB2, KDR, and Flt-1. In cells, growth factor-induced
AEE788
Protein-coding gene in the species Homo sapiens
manner (IC50 = 44 μM) by inhibiting the hydrolysis of peptide substrates. At the same time it acts as a competitive inhibitor against ERAP1 (IC50 = 73 μM)
ERAP2
Toxin from the Chilean tarantula venom
Channels IC50 Cav3.1 0.01 μM Nav1.7 0.007 μM Nav1.3 0.12 ± 0.06 μM Nav1.5 No significant effect (up to 2 μΜ) Nav1.8 No significant effect (0.93 μM)
GTx1-15
Chemical compound
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
Phenmetrazine
Pharmaceutical compound
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
2-Phenylmorpholine
Chemical compound
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
MDMAR
agonists (e.g. flumazenil). Low IC50 or high pIC50 values indicate tighter binding (pIC50 of 8.0 = IC50 of 10nM, pIC50 of 9.0 = IC50 of 1nM, etc.) These are non
List_of_benzodiazepines
Locomotive-hauled long-distance passenger rail service in Germany
Intercity, often shortened to IC ([iːˈtseː] ), is the second-highest train classification in Germany, after the Intercity Express (ICE). Intercity services
Intercity_(Deutsche_Bahn)
Stimulant and entactogen drug of the amphetamine class
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
4-Methylmethamphetamine
Chemica compound, Agonist of Rev-ErbA
Rev-ErbA) with a half-maximum inhibitory concentration (IC50) = 670 nM for Rev-ErbAα and IC50 = 800 nM for Rev-ErbAβ. In an animal study, some of its
SR9009
Chemical compound
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
Aminorex
Pharmaceutical compound
of MAO-A (IC50 = 5,630 nM), but was about 13-fold less potent than 2-NAP. Neither 2-NAP or 1-NAP inhibited monoamine oxidase B (MAO-B) (IC50 > 100,000 nM)
1-Naphthylaminopropane
Class of enzymes
(IC50=7.5μM) TDZD-8 (IC50=2μM) NP00111 (IC50=2μM) NP031115 (IC50=4μM) Tideglusib (IC50=60nM) HMK-32 (IC50=1.5μM) L803-mts (IC50=20μM) L807-mts (IC50=1μM)
GSK-3
Chemical compound
receptor antagonist, which is a non-competitive AMPA receptor antagonist (IC50 values are 10-20, ~ 450 and >> 50 μM for AMPA-, kainate- and NMDA-induced
GYKI_52466
Weight loss medication
of potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). [...] Chlorphentermine was a very potent 5-HT releaser (IC50 = 18.2 nM), a weaker
Phentermine
Chemical compound
Rev-ErbAα with a half-maximum inhibitory concentration (IC50) = 790 nM for Rev-Erbα and IC50 = 560 nM for Rev-ErbAβ. It has been used in the study of
SR9011
Chemical compound
of [125I] RTI-55 (IC50 = 4.82 ± 0.05 μM, n=3) to human recombinant DAT expressed in CHO-K1 cells and inhibition of DA uptake (IC50 = 14.5 ± 1.6 μM, n=2)
Phenylpiracetam
Chemical compound
tyrosine-kinase inhibitor with activity against EGFR (IC50 0.8 nM), HER-2 (IC50 19 nM) and ErbB-4 (IC50 7 nM). By 2015, Pfizer had discontinued development
Canertinib
Group of chemical compounds
of 1,700 nM. It is also a weak dopamine reuptake inhibitor (DRI), with an IC50 of 3,040 nM at the dopamine transporter (DAT). The drug shows weak affinity
Β-Carboline
Chemical compound
leaves of Piper betle. It is a more potent inhibitor of xanthine oxidase (IC50=16.7 μM) than allopurinol. It might be a useful new compound in treating
Hydroxychavicol
Chemical compound
MDPHP acts as a potent norepinephrine-dopamine reuptake inhibitor. The IC50 values for MDPHP are 60-935 nM at NET, 8.4-50 nM at DAT and 9000 nM at SERT
MDPHP
Chemical compound
Tesofensine has IC50 of 8.0, 3.2 and 11.0nM at the DAT, NET, and SERT. More recently, though, the following data was submitted: IC50 (nM) NET 1.7, SERT
Tesofensine
Medication used to treat Alzheimer's disease
antagonist, with an IC50 binding affinity of ~500-1,000 nM (0.5-1 μM), but displays higher potency at extrasynaptic NMDA receptors (IC50 = ~22 nM), suggesting
Memantine
Chemical compound
hydrolase (FAAH), with an IC50 of 9.1nM, and 870x selectivity for FAAH over the related enzyme MAGL, which it inhibits with an IC50 of 7900nM. It is also
4-Nonylphenylboronic_acid
Chemical compound
transporter (DAT) has been reported to be 6,360 nM and its functional inhibition (IC50) of the DAT has been reported to be 3,780 to 8,800 nM. These values were
2-Benzylpiperidine
Group of stereoisomers
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
4-Methylaminorex
Drug discovery
n-pentyl group (IC50 = 13,3 nM), n-butyl (IC50 = 119 nM), phenyl with 2-furyl (IC50 = 0,720) or 3-thiophenyl (IC50 = 0,772). As seen in table 1, the in vitro
Discovery and development of gliflozins
Discovery_and_development_of_gliflozins
collection of experimentally measured binding affinity data (Kd, Ki, and IC50) for the protein-ligand complexes deposited in the Protein Data Bank (PDB)
PDBbind_database
Pharmaceutical compound
have much higher affinity for serotonin receptors than RU-27849 itself (IC50 ≈ 50 nM). A number of other derivatives also exist, including FHATHBIN (6-hydroxy)
RU-27849
Stimulant and anorectic drug of the amphetamine class
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
4-Methylamphetamine
Chemical compound
inhibitor of protein kinase JAK-2 with IC50=6 nM; related kinases FLT3 and RET are also sensitive, with IC50=25 nM and IC50=17 nM, respectively. Significantly
Fedratinib
Chemical compound
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
Naphthylaminopropane
Pharmaceutical compound
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
Naphthylmetrazine
Chemical compound
selective inhibitor of serine/threonine-protein kinase 33 (STK33), with a IC50 of 9.2 nM. In animal studies it causes production of abnormal sperm with
CDD-2807
Substituted cathinone stimulant drug
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
2-Naphthylmethcathinone
Concentration of a compound where 50% of its maximal effect is observed
(x axis). For competition binding assays and functional antagonist assays IC50 is the most common summary measure of the dose-response curve. For agonist/stimulator
EC50
Chemical compound
hydroxyflutamide as the active form. It has been reported to possess an IC50 of 700 nM for the androgen receptor (AR), which is about 4-fold less than
Hydroxyflutamide
Chemical compound
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
Methamnetamine
Chemical compound
negative allosteric modulator of the α7-nicotinic acetylcholine receptor (IC50 = 55 nM). For this reason, similarly to hydroxynorketamine (HNK), it has
Dehydronorketamine
Class of drugs
of [125I] RTI-55 (IC50 = 4.82 ± 0.05 μM, n=3) to human recombinant DAT expressed in CHO-K1 cells and inhibition of DA uptake (IC50 = 14.5 ± 1.6 μM, n=2)
Racetam
Genus of eusocial wasp
its IC50 was nearly 128 μL, so we confirmed that LDH absorbance was not affected by this peptide." p. 262, "Moreover, the results showed the IC50 of mast
Hornet
Chemical compound
testing determined APICA to have an IC50 of 175 nM at CB1, only slightly less potent than JWH-018 which had an IC50 of 169 nM, but over four times more
APICA (synthetic cannabinoid drug)
APICA_(synthetic_cannabinoid_drug)
Substance that forms a complex with a biomolecule
the receptor. Ligand affinities are most often measured indirectly as an IC50 value from a competition binding experiment where the concentration of a
Ligand_(biochemistry)
Measure of a ligand's binding energy per atom
non-hydrogen atoms. It can be transformed to the equation: LE = 1.4(−log IC50)/N Some suggest that better metrics for ligand efficiency are percentage/potency
Ligand_efficiency
Chemical compound
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
Pseudophenmetrazine
Medication mainly used for depression and smoking cessation
7,600–28,000 IC50 Human α3β2-nACh 1,000 IC50 Human α3β4-nACh 1,800 IC50 Human α4β2-nACh 12,000 IC50 Human α4β4-nACh 12,000–14,000 IC50 Human α7-nACh
Bupropion
Pharmaceutical compound
concentration = 33–700 nM) and a very weak dopamine reuptake inhibitor (IC50 = 12,000 nM). Conversely, it is not a dopamine transporter (DAT) substrate
Harmine
Chemical compound
Especially, Carpaine possessed significant anti-plasmodial activity in vitro (IC50 of 0.2 μM) and high selectivity towards the parasites. Circulatory effects
Carpaine
Type of receptor ligand or drug that blocks a biological response
antagonist is usually defined by its half maximal inhibitory concentration (i.e., IC50 value). This can be calculated for a given antagonist by determining the
Receptor_antagonist
Parameter used in drug design
defined as the pIC50 (or pEC50) of interest minus the LogP of the compound. LiPE = pIC 50 − log P {\displaystyle {\ce {LiPE}}={\ce {pIC50}}-\log P} In
Lipophilic_efficiency
SNDRI antidepressant drug
norepinephrine reuptake, respectively, toludesvenlafaxine has respective in vitro IC50 values of 723 nM, 763 nM, and 491 nM for serotonin, norepinephrine, and dopamine
Toludesvenlafaxine
Chemical compound
acid, 4-butylresorcinol has been found to be the most powerful inhibitor by IC50, but the mode of inhibition is reversible. 4-Butylresorcinol can be used
4-Butylresorcinol
Opioid analgesic
lesser extent as a partial agonist of the μ-opioid receptor (Ki = 0.25 nM; IC50 = 3.4 nM; Imax = 29%) with lower relative intrinsic activity and marked antagonistic
Xorphanol
Chemical compound
concentration is 25μM, the IC50 of andrographolide for GSK-3β is 5.58±0.40μM. When the substrate concentration is increased to 90μM, the IC50 increases to 37.7μM
Andrographolide
Chemical compound
hormone receptor (GnRHR), with a half-maximal inhibitory concentration (IC50) of 0.12 nM. A dosage of relugolix of 40 mg once per day has been found to
Relugolix
Substituted cathinone stimulant drug
inhibitor and dopamine reuptake inhibitor. It binds to transporters with IC50 values of 37 nM (dopamine transporter), 105 nM (norepinephrine transporter)
N-Ethylpentylone
Chemical compound
extracts. Clavaric acid is a reversible farnesyltransferase inhibitor with an IC50 of 1.3 μM. Lingham RB, Silverman KC, Jayasuriya H, Kim BM, Amo SE, Wilson
Clavaric_acid
Drug discovery
benzimidazole-benzimidazole structure on inhibitory activity Structure Activity X IC50 (nM) Inhibitory activity >44 None >44 None 11 Very weak 1.7 Weak 0.50 Moderate
Discovery and development of NS5A inhibitors
Discovery_and_development_of_NS5A_inhibitors
Chemical compound
class which acts as a selective serotonin releasing agent (SSRA). It has IC50 values of 121 nM, 6,436 nM, and 3,371 nM for inhibiting the reuptake of serotonin
6-APT
Antidepressant medication
acts as a serotonin reuptake inhibitor (IC50 = 2.1 nM; Ki = 0.1 nM) and 5-HT1A receptor partial agonist (IC50 = 0.2 nM; IA = ~60–70%). It has negligible
Vilazodone
Chemical compound
kidney injury. It acts as a non-selective melanocortin receptor agonist, with IC50 values of 2.9 nM, 1.9 nM, 3.7 nM, and 110 nM at the MC1, MC3, MC4, and MC5
Modimelanotide
Chemical compound
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
4,4'-Dimethylaminorex
Protein from Chinese tarantula venom
disulfide bridges. Jingzhaotoxins can target multiple channels. The following IC50 values have been determined: '*' Only a dissociation constant (Kd) was measured
Jingzhaotoxin
Medication
1, 2, 3 inhibitor Fruquintinib was found to inhibit VEGFR2 (KDR) with an IC50 of 25 nmol/L in the Z-lyte assay. The kinase selectivity of fruquintinib
Fruquintinib
Chemical compound
cancer cells. It demonstrates a strong inhibitory effect on CDK9, with an IC50 of 79 nM, while showing considerably weaker activity against other cyclin-dependent
Toyocamycin
Chemical compound
phosphoinositide 3-kinases (PI3Ks). It has an in vitro inhibitory concentration (IC50) of around 5 nM, making it a more potent inhibitor than LY294002, another
Wortmannin
Compounds that inhibit histone deacetylases
manner with a median inhibitory concentration (IC50) of 5.3, 2.4, and 4.5 mM, respectively. The HDAC6 IC50 was much higher (48.5 mM) (Fig. 1E), and βOHB
Histone_deacetylase_inhibitor
Pharmaceutical compound
modulator or allosteric inhibitor of the serotonin transporter (SERT), with an IC50 of 43.8 nM in the later study. Lu 35-138 also shows affinity for the α1-adrenergic
Lu_35-138
Chemical compound
Sclerotiorin is an aldose reductase inhibitor (IC50=0.4 μM) as well as a reversible lipoxygenase inhibitor (IC50=4.2 μM). Chidananda, C; Rao, LJ; Sattur, AP
Sclerotiorin
Chemical compound
substance which acts as a potent agonist at the 5-HT7 receptor, with an IC50 of 0.83 nM. It reverses the amnesia induced by drugs such as scopolamine
AS-19_(drug)
Antiprogestogen and antiglucocorticoid drug
steroidal antiprogestogen (IC50 = 0.025 nM for the PR), as well as an antiglucocorticoid (IC50 = 2.2 nM for the GR) and antiandrogen (IC50 = 10 nM for the AR)
Mifepristone
Chemical compound
crenolanib is toxic at IC50 concentrations of 7 nM and 8 nM, respectively. Crenolanib has been shown to inhibit PDGFRα with an IC50 of 0.4 ng/mL in porcine
Crenolanib
Chemical compound
it is an extremely potent uncoupler of oxidative phosphorylation with an IC50 of about 1 micromolar (≈500 nanograms per milliliter or parts per billion)
Perfluorooctanesulfonamide
Chemical compound
shows significant antitumor properties in vitro (IC50=480nM against mouse B16 melanoma cells and IC50=500nM against P388 leukemia cells). It is an antineoplastic
Rebeccamycin
Species of flowering plant
cell line (IC50: 19.25 µg/mL after 24 hours), while the water sub-extract showed activity against the MDA-MB-231 breast cancer cell line (IC50: 15.20 µg/mL)
Silene_latifolia
Chemical compound
spectabilis. It can be consumed orally, smoked, or snorted. It is a potent (IC50 < 1 μM) selective inhibitor of the serotonin transporter (SERT) (that is
Mesembrenone
Pharmaceutical compound
benzo[b]furan isostere. The tryptamine IC50 of 38 nM was about 13-fold lower than the benzofuran, which had an IC50 of 500 nM. Nichols DE (2012). "Structure–activity
Mebfap
Protein family
C-terminal carboxyl is replaced by an amide. ShK-186 blocks Kv1.3 with an IC50 of 69 pM and exhibits the same specificity for Kv1.3 over closely related
Stichodactyla_toxin
Units used in toxicology
required to cause a given toxicological endpoint (LC50, EC50, IC50). 1TU=LC50 or 1TU=IC50 for inhibition of growth Since the mass or molar based concentrations
Toxic_unit
Chemical compound
and 3,349 nM for serotonin in rat brain synaptosomes. Similarly, MDPV's IC50 values for monoamine reuptake inhibition were 10 nM for dopamine, 80 nM for
Methylenedioxypyrovalerone
Pharmaceutical drug
of [125I] RTI-55 (IC50 = 4.82 ± 0.05 μM, n=3) to human recombinant DAT expressed in CHO-K1 cells and inhibition of DA uptake (IC50 = 14.5 ± 1.6 μM, n=2)
MRZ-9547
Chemical compound
development for treatment of hematological malignancies. It has lowest nM IC50 values against TYK2, JAK1, JAK2, JAK3, FMS, and SYK. It is being developed
Cerdulatinib
Pharmaceutical compound
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
Ethylnaphthylaminopropane
Chemical compound
which initiates apoptosis. MG132 also inhibits NF-κB activation with an IC50 of 3 μM and prevents β-secretase cleavage. There are several inhibitors that
MG132
Pharmaceutical compound
potency NE (IC50 = 28.8 nM)> DA (IC50 = 262 nM)> 5-HT (IC50 = 2575 nM). Aminorex released NE (IC50 = 26.4 nM), DA (IC50 = 44.8 nM) and 5-HT (IC50 = 193 nM)
Naphthylmorpholine
Appetite suppressant
transporter 0.45–18 (Ki) 0.92–4.9 (IC50) >10,000 (EC50) SERTTooltip Serotonin transporter 39–272 (Ki) 54–94 (IC50) >10,000 (EC50) SERT2Tooltip Serotonin
Mazindol
Chemical compound
permeable inhibitor of Ca2+/calmodulin-dependent kinase type II (CaMK II) with IC50 of 900nM, charactered by hydrophobicity. KN-62 also potently inhibits the
KN-62
Pharmaceutical compound
chemokine CXCR3 receptor antagonist, with an affinity (IC50) of 54 nM and an inhibitory potency (IC50) of 18 to 74 nM. Unlike NIBR2130, LSD itself is completely
NIBR2130
Drug for wakefulness and alertness
of [125I] RTI-55 (IC50 = 4.82 ± 0.05 μM, n=3) to human recombinant DAT expressed in CHO-K1 cells and inhibition of DA uptake (IC50 = 14.5 ± 1.6 μM, n=2)
Eugeroic
Pharmaceutical compound
for the glutamate receptor mGluR3. It has only moderate potency with an IC50 of 450 nM, but is highly selective over the closely related subtype mGluR2
ML337
Metabolite of bupropion
been reported to inhibit α3β4 nicotinic acetylcholine receptors, with an IC50 value of 14 μM. Threohydrobupropion circulates at higher concentrations than
Threohydrobupropion
Investigational gamma-secretase modulator
species such as Aβ38 and Aβ37. The compound demonstrates high potency with an IC50 below 10 nM for gamma-secretase modulation of APP cleavage, and importantly
Nivegacetor
Chemical compound
a IC50 5.0 ug/mL, nonetheless, human cathepsin L is involved in many diseases, gallinamide A was tested in HeLa cervical cancer cells with a IC50 12
Gallinamide_A
Chemical compound
5-HT)) and 5-HT2B receptor antagonist (IC50 = 29 nM). It is also a very weak antagonist at the 5-HT2A receptor (IC50 = 1,650 nM), though this action is not
Vabicaserin
Chemical compound
affinity was measured at the CB1 and CB2 receptors and it was found to have an IC50 of 591 nM at CB1 and 968 nM at CB2, making it 2.3 times and 9.4 times weaker
Cannabipiperidiethanone
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50